10/07/2024 6:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/30/2024 7:07 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/20/2024 3:20 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/19/2024 3:10 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form PRE 14A | |
|
07/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/24/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form EFFECT | |
07/24/2024 4:11 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 424B3 | |
07/18/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/16/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/10/2024 10:11 AM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4/A | |
06/26/2024 8:15 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/25/2024 3:15 PM | DONG-A ST CO., LTD (Filed by) NeuroBo Pharmaceuticals, Inc. (Subject) NeuroBo Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/25/2024 3:16 PM | DONG-A ST CO., LTD (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/25/2024 7:21 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 424B5 | |
06/25/2024 7:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/24/2024 5:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:24 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) STRICKLAND D GORDON (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | Glickman Mark A (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:25 PM | KOVEN ANDREW I (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | GROVES JASON L (Reporting) NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/07/2024 6:26 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Salsbury Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 7:05 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/30/2024 7:41 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form DEF 14A | |
04/30/2024 7:42 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form ARS | |
04/30/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/23/2024 11:15 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form EFFECT | |
04/17/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/16/2024 3:30 PM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/01/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 7:01 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/04/2024 8:20 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Woodworth Marshall H (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/29/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 7:52 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
True paradigm shift (Ad) I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was.
Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. |
02/01/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/18/2024 7:30 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 7:45 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/28/2023 8:00 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/19/2023 8:03 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/07/2023 8:20 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/04/2023 4:12 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Tursi James Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/06/2023 7:20 AM | NeuroBo Pharmaceuticals, Inc. (Filer) NeuroBo Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:39 PM | NeuroBo Pharmaceuticals, Inc. (Issuer) NeuroBo Pharmaceuticals (Issuer) Tursi James Patrick (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |